Are you invested in Co-Diagnostics (CODX)?
What’s up with Co-Diagnostics?
Co-Diagnostics (CODX) opened at $17.54, which means the stock is down 2.61% from yesterday’s closing price of 18.03. Today, the company has a high of $17.72 and a low of $15.88. The company has a market cap of $482.14 million with a 52-week high of $29.72 and a 52-week low of $0.69.
What about the future for Co-Diagnostics?
The high forecast for Co-Diagnostics is $25.00 while the low is $9.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Co-Diagnostics has a weak forecast. A weak forecast is due to the company posting consistent losses in their earning reports. The future outlook does not seem too bright as this could potentially cause the company to file for bankruptcy. Based on this information CODX seems to be a risky buy.
Co-Diagnostics, Inc. engages in the development, manufacture, and marketing of diagnostics technology. It offers design services, vector control, equipment, diagnostic, and research solutions. The company was founded by Brent C. Satterfield and Dwight H. Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.